Pulmonary Hypertension (Ayerza Syndrome) Summary

Networked: 10739 relevant articles (731 outcomes, 1142 trials/studies) for this Disease

Key Drugs and Agents for Pulmonary Hypertension

1. Nitric Oxide (Nitrogen Monoxide) : 84 outcomes 113 studies in 1035 results : FDA 1
   
2. sildenafil (Viagra) : 57 outcomes 72 studies in 454 results : FDA 5
   
3. Epoprostenol (Prostacyclin) : 56 outcomes 45 studies in 446 results : FDA 4 Generic
   
4. Monocrotaline : 35 outcomes 86 studies in 564 results : IBA
   
5. Oxygen : 32 outcomes 38 studies in 503 results : IBA
   
6. bosentan (Tracleer) : 30 outcomes 37 studies in 194 results : FDA 1
   
7. Iloprost (Ventavis) : 28 outcomes 29 studies in 180 results : FDA 1
   
8. Idiopathic pulmonary hypertension : 20 outcomes 59 studies in 666 results : IBA
   
9. Vasodilator Agents (Vasodilators) : 19 outcomes 20 studies in 204 results : IBA
   
10. Alprostadil (Muse) : 17 outcomes 9 studies in 99 results : FDA 8 Generic
    

Diseases Related to Pulmonary Hypertension

1. Anoxia (Hypoxia)
2. Heart Failure
3. Chronic Obstructive Pulmonary Disease (COPD)
4. Heart Diseases (Heart Disease)
5. Lung Diseases (Lung Disease)

Key Therapies for Pulmonary Hypertension

1. Endarterectomy (Thromboendarterectomy) : 38 outcomes 21 studies in 362 results
   
2. Extracorporeal Membrane Oxygenation (ECMO) : 20 outcomes 13 studies in 256 results
   
3. Lung Transplantation : 15 outcomes 15 studies in 234 results
   
4. Transplantation (Transplant Recipients) : 12 outcomes 7 studies in 185 results
   
5. Heart Transplantation (Grafting, Heart) : 11 outcomes 21 studies in 194 results